Anthony J. Polverino
Director/Board Member presso BRAINSTORM CELL THERAPEUTICS INC.
Patrimonio netto: 14 667 $ in data 31/03/2024
Profilo
Anthony J.
Polverino is an Independent Director at Brainstorm Cell Therapeutics, Inc. He was previously an Executive Director at Amgen, Inc., Chief Scientific Officer at Kite Pharma, Inc., and Chief Scientific Officer & EVP-Early Development at Zymeworks BC, Inc. Polverino received his undergraduate degree from the University of Adelaide and his doctorate from Flinders University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 31/10/2023 | 25 960 ( 0.05% ) | 14 667 $ | 31/03/2024 |
Posizioni attive di Anthony J. Polverino
| Società | Posizione | Inizio |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Director/Board Member | 05/02/2018 |
Precedenti posizioni note di Anthony J. Polverino
| Società | Posizione | Fine |
|---|---|---|
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | 19/01/2022 |
| KITE PHARMA INC | Chief Tech/Sci/R&D Officer | 01/01/2018 |
| AMGEN INC. | Corporate Officer/Principal | - |
Formazione di Anthony J. Polverino
| University of Adelaide | Undergraduate Degree |
| Flinders University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Borsa valori
- Insiders
- Anthony J. Polverino
